
Carlsmed Inc (CARL) Stock Forecast & Price Target
Carlsmed Inc (CARL) Analyst Ratings
Bulls say
Carlsmed is a commercial-stage medical technology company that has shown significant revenue growth and profitability with their AI-enabled personalized solutions for spine surgery. The company's strong competitive position and plans for expanding their product offerings and territories support their potential for continued growth and success in the market. However, competition, pricing pressure, and reliance on contract manufacturers pose potential risks to their future performance.
Bears say
Carlsmed is currently trading at a significant discount to its small/mid-cap growth group's median EV/sales multiple, which suggests lower growth prospects. While increased adoption of their personalized spine solutions and the launch of a new cervical platform could drive growth, there are still risks such as a concentrated customer base and the need for additional capital to reach profitability. Additionally, the company's limited operating history and competition in the market pose potential challenges.
This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.
Carlsmed Inc (CARL) Analyst Forecast & Price Prediction
Start investing in Carlsmed Inc (CARL)
Order type
Buy in
Order amount
Est. shares
0 shares